A Fiber from Jerusalem Artichoke Cut Weight Gain by 20% in Obese Mice

A fiber fraction pulled from Jerusalem artichoke reduced body weight gain by up to 20% in mice fed a high-fat diet, according to preliminary research published in Phytomedicine. The compound, called medium-chain inulin, reshaped the composition of gut bacteria, restored beneficial fatty acid production, and shifted the metabolic chemistry of the gut in ways that correlated with lower body weight, lower cholesterol, and improved blood sugar. The results are early and come from a mouse model, but they offer one of the clearest mechanistic pictures yet of how fiber chain length may drive distinct biological effects.

Medium-Chain Inulin's Effect on Body Weight and Lipid Profiles

Inulin is already known as a prebiotic fiber: bacteria in the distal gut ferment it into short-chain fatty acids (SCFAs), compounds that regulate inflammation, appetite signaling, and fat metabolism. What is less understood is whether the length of the inulin chain changes what the fiber actually does. Medium-chain inulin falls in a degree of polymerization (DP) range of 10 to 20, meaning each molecule is a chain of 10 to 20 fructose-derived units. The inulin used in this study, extracted from Helianthus tuberosus with an average DP of 12, was fed to male C57BL/6 mice at doses of 1%, 3%, and 5% of diet for 12 weeks alongside a high-fat diet.

Mice receiving the 3% dose saw body weight gain fall by 16% relative to the untreated high-fat diet group. The 5% dose pushed that reduction to 20%. Beyond body weight, serum triglycerides, total cholesterol, LDL, and fasting blood glucose all dropped, while HDL cholesterol rose. Liver sections stained with Oil Red O showed dose-dependent reductions in hepatic lipid accumulation. Liver and white adipose tissue weights fell, and brown adipose tissue weight increased, a pattern associated with greater thermogenic activity.

Why Gut Bacteria and Metabolites Both Shifted

High-fat diets are consistently associated with a disrupted gut microbiome: lower bacterial diversity and a higher ratio of Firmicutes to Bacteroidota (F/B ratio), a balance linked in prior research to obesity and metabolic dysfunction. Medium-chain inulin reversed both changes. Microbial alpha-diversity recovered, and the F/B ratio fell toward levels seen in the standard chow group.

At the genus level, the inulin enriched Faecalibaculum, Bifidobacterium, Akkermansia, Lactobacillus, Bacteroides, Parasutterella, and Clostridium_sensu_stricto_1. Several of these, particularly Clostridium_sensu_stricto_1, showed positive correlations with SCFA levels and negative correlations with body weight in co-occurrence network analysis. The inulin also reduced the relative abundance of Lachnospiraceae_NK4A136_group, Dubosiella, Alistipes, and Colidextribacter, genera that had expanded on the high-fat diet.

SCFA levels in cecal samples followed a dose-dependent pattern: acetic acid and butyric acid rose with higher inulin doses, while branched-chain fatty acids, which are associated with protein fermentation and metabolic inflammation, fell.

How the Researchers Mapped Microbiome and Metabolome Together

The study combined 16S rRNA sequencing of cecal bacteria with untargeted LC-MS/MS metabolomics, an approach that requires integrating complex multi-omics datasets to link microbial shifts to downstream chemistry. The metabolomic screen identified 1,503 cecal metabolites, and a multivariate analysis called OPLS-DA cleanly separated the high-fat diet group from both the control and inulin-treated groups.

Medium-chain inulin upregulated eight metabolite classes of particular interest. Nicotinamide, a form of vitamin B3 involved in energy metabolism, increased. Taurocholic acid, a bile acid, rose alongside other taurine-conjugated compounds. Tryptophan-derived metabolites climbed, including 5-hydroxytryptophan and 2-(1H-indol-3-yl)acetic acid, an indole derivative whose levels correlated negatively with body weight, serum triglycerides, total cholesterol, and LDL across animals. Steroid hormones including aldosterone, corticosterone, and 5-alpha-dihydrotestosterone also increased.

On the downside of the equation, the inulin suppressed arachidonic acid, prostaglandin D2, and docosahexaenoic acid, all lipid-class metabolites that had elevated on the high-fat diet, as well as retinoic acid derivatives. Pathway analysis pointed to modulation of tryptophan metabolism, primary bile acid biosynthesis, nicotinate and nicotinamide metabolism, and steroid hormone biosynthesis as the main affected routes.

Key Limitations Before Human Applications Are Considered

The study has several constraints worth holding in mind. All animals were male, so potential sex-specific responses remain unknown. The correlations between microbes, metabolites, and metabolic outcomes are associations, not causal demonstrations: the authors explicitly note that further mechanistic work is required to establish which relationships are driving which outcomes. The metabolomics data came from untargeted profiling, meaning the absolute quantities of key metabolites need targeted validation before they can be relied upon.

The study also did not directly compare medium-chain inulin against short-chain or long-chain inulin variants, commercial inulin products, or combination formulations, so the claim that chain length specifically matters rests on inference rather than head-to-head evidence. Most importantly, clinical studies in humans have not yet been done, and mouse metabolic studies frequently do not replicate at human doses or in human physiology.

What Comes Next for Chain-Length-Specific Prebiotic Research

The study positions medium-chain inulin, particularly at DP around 12, as a candidate worth investigating in controlled human trials. Future research directions flagged by the authors include sex-matched studies, targeted metabolite quantification, and direct comparisons across inulin chain lengths. Researchers in the field have called for standardized clinical protocols and degree-of-polymerization-based evaluations to move prebiotic science toward personalized formulations, and this study adds structural and mechanistic detail that could inform that design work.

For now, the findings are best read as a mechanistic proof of concept. Medium-chain inulin, drawn from a widely cultivated crop and fed at doses equivalent to a meaningful but achievable dietary fiber increment, altered the gut environment of obese mice in a coordinated way, from bacteria through metabolites to tissue-level lipid deposition. Whether that cascade translates to humans, and at what dose, remains the central open question.

Evidence rating

INVESTIGATIONAL — 71/100

Caveats:

• All experiments were conducted in male mice only; results have not been tested in humans.
• Correlation and network analyses cannot establish causation between specific microbes, metabolites, and metabolic outcomes.
• Key metabolomic findings are untargeted and require targeted quantitative validation.
• No direct comparison was made to other inulin chain lengths or commercial prebiotic products.
• Funding source was not disclosed by the authors.

Preclinical study in 40 male C57BL/6 mice across five dietary groups over 12 weeks. Demonstrates associations between medium-chain inulin supplementation and shifts in gut microbiota composition, SCFA production, and metabolic markers, but cannot establish causation in humans. Findings have not been independently replicated or validated in clinical populations.

References

1. Yunpeng Wang, Eunyoung Kim, Jiamei Cui, Yunkyoung Lee, Guiguo Zhang (2026). Medium-chain inulin reshapes the gut microbiome-metabolome axis to counteract high-fat diet-induced obesity. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158423
2. Zeang Wu, Zhenzhu Du, Yuanyuan Tian, et al. (2022). Inulin accelerates weight loss in obese mice by regulating gut microbiota and serum metabolites. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2022.980382
3. Pamela Vernocchi, Federica Del Chierico, Lorenza Putignani (2016). Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2016.01144
4. Ekkarit Panichsillaphakit, Chonnikant Visuthranukul, Yuda Chongpison, et al. (2025). The effects of inulin supplementation on eating behaviours in children and adolescents with obesity: a randomized double-blinded placebo-controlled study. Nutrition & Metabolism. https://doi.org/10.1186/s12986-025-00995-0
5. Nevin Sanlier, Mihriye Gül Keskin, Fatih Oz (2026). Inulin as a multifunctional prebiotic: from gut modulation to systemic health benefits. Food Quality and Safety. https://doi.org/10.1093/fqsafe/fyag006